I am sitting in the airport in Baltimore waiting to head back to Saint Petersburg. I was here to attend the PQA annual meeting. During this meeting, we heard from professional leaders as they discussed the progress that the Pharmacy Quality Assurance organization had made in ensuring better patient care …

Dr. Andrew J.M. Boulton, MD, DSc, FRCP, Professor of Medicine, University of Manchester speaks with Diabetes in Control publisher Steve Freed about the global epidemic of diabetes.

Post-marketing trial data show doubled rates compared to placebo.

Youths who received any breastfeeding for at least 12 months or full breastfeeding for at least six months had lower odds of developing type 1 diabetes.

Besides lowering A1c, study finds success with using less insulin and weight reduction.

A low-risk intervention with potentially high rewards.

A proposed benefit of GLP-1 agonists confirmed in a human study.

What proportion of Americans age 45 and older have self-reported memory problems? 1. 1 in 30 2. 1 in 16 3. 1 in 9 4. 1 in 4 Follow the link to see the correct answer!

To your type 1 patients who use large amounts of insulin or are overweight, have you recommended the use of a GLP-1 receptor agonist in their treatment? (See Article #3) 1) Yes 2) No 3) No, but will now consider What do your colleagues think? Follow the link to find out!

Dr. Andrew J.M. Boulton talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the worldwide state of diabetes, the impact by society, and treatment options.